All In Biotech

Drug Trial Radar · NCT03452488

A Double-blind, Placebo-controlled, Randomized INTerventional Clinical Trial (SARA-INT)

Safety and Efficacy of BIO-101 175 mg b.i.d. and 350 mg b.i.d. 26-week Oral Administration to Patients Suffering From Age-related SARcopenia, Including Sarcopenic Obesity, Aged ≥65 Years and at Risk of Mobility Disability

Last checked: Nov 19, 2026Latest source record: Oct 1, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 233 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

233

Actual

Start

Feb 7, 2017

Primary completion

Apr 26, 2020

Study completion Apr 26, 2020

Sponsor

Lead sponsor
BiophytisIndustry
Sponsor type
Industry
First posted
Mar 2, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main objective of the study is to evaluate the effect of two daily doses of BIO101 versus placebo on mobility function as measured by gait speed using the 400MW test. The absolute change from baseline in meters/second observed in each treatment group at 6 Month was compared to the placebo group. Due to the Covid pandemic \>50% of data at endpoint was missing, which may have affected the ability of the study to deliver the expected results. Additionally, although the planned duration of treatment was 6 months, it was extended up to 9 months for some participants as a result of the pandemic.

Conditions

  • Sarcopenia
  • Gait Disorders in Old Age
  • Muscle Weakness

Interventions

  • BIO101Drug

    Oral capsules

  • PlaceboDrug

    Oral capsules

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline to 6 Months in Gait Speed for 400 Meter Walking (MW) TestTime frame: Baseline and 6 Months

Locations

22 sites in 2 countries. Site status is shown where the registry gives one.

  • Advanced Clinical Research

    Banning, California

  • SC Clinical Research, Inc

    Garden Grove, California

  • California Research Foundation

    San Diego, California

  • Institut On Aging

    Gainesville, Florida

  • Jax-Ascent University of Florida

    Jacksonville, Florida

  • PANAX Clinical Research

    Miami Lakes, Florida

  • Clinical Research of Central Florida

    Plant City, Florida

  • Pennington Biomedical Research Center

    Baton Rouge, Louisiana

  • Jean Mayer USDA Human Nutrition research Center on Aging Tufts University

    Boston, Massachusetts

  • New Mexico Clinical Research & Osteoporosis Center

    Albuquerque, New Mexico

  • Columbia University

    New York, New York

  • PMJ Research of Wilmington

    Wilmington, North Carolina

  • Bowman Gray Center for Medical Education-of- Wake Forest School of Medicine

    Winston-Salem, North Carolina

  • Tekton Research

    Yukon, Oklahoma

  • Tekton Research

    Austin, Texas

  • Medical Center

    Houston, Texas

  • Science Advancing Medicine Clinical Research Center

    San Antonio, Texas

  • The University of Texas Health Science Center at San Antonio

    San Antonio, Texas

  • Advanced Clinical Research

    West Jordan, Utah

  • Vrije Universiteit Brussel

    Brussels, Belgium

  • Universitaire Ziekenhuizen (UZ) Leuven - Gasthuisberg - Centrum voor metabole botziekten

    Leuven, Belgium

  • Université de Liège

    Liège, Belgium

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.